A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimic.

Methods Mol Biol

Mirna Therapeutics, 2150 Woodward Street, Suite 100, Austin, TX, 78744, USA,

Published: March 2016

MRX34 has recently entered the clinic as the first therapeutic product based on a microRNA (miRNA) mimic. In order to measure drug concentrations in vivo, a quantitation method is needed that exhibits high precision, accuracy, and robustness. While most clinical applications for oligonucleotide therapeutics involve methods based on hybridization assays and liquid chromatography-tandem mass spectrometry, quantitative PCR (qPCR) is a less well-described approach. Here, we present an RT, qPCR, and analysis method to determine the tissue biodistribution of endogenous as well as a therapeutic, exogenous miRNA mimic therapeutic. Assay performance is demonstrated on multiple tissues from nonhuman primates dosed with MRX34.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-2727-2_8DOI Listing

Publication Analysis

Top Keywords

mirna mimic
8
qrt-pcr method
4
method determining
4
determining biodistribution
4
biodistribution profile
4
profile mir-34a
4
mir-34a mimic
4
mimic mrx34
4
mrx34 entered
4
entered clinic
4

Similar Publications

Objectives: MicroRNAs (miRNAs) play a crucial role in the onset and progress of obesity. The inflammation of adipose tissue is deemed causative of the complications associated with obesity. This study delved into the potential mechanisms of miRNA-mediated SIRT1 regulation and inflammatory factors modulation in 3T3-L1 cells.

View Article and Find Full Text PDF

Cancer is a complex genetic disorder characterized by abnormalities in both coding and regulatory non-coding RNAs. microRNAs (miRNAs) are key regulatory non-coding RNAs that modulate cancer development, functioning as both tumor suppressors and oncogenes. miRNAs play critical roles in cancer progression, influencing key processes such as initiation, promotion, and metastasis.

View Article and Find Full Text PDF

Human miR-1 Stimulates Metabolic and Thermogenic-Related Genes in Adipocytes.

Int J Mol Sci

December 2024

Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty of Health and Sport Science, University of Zaragoza, 50009 Zaragoza, Spain.

MicroRNAs play a pivotal role in the regulation of adipose tissue function and have emerged as promising therapeutic candidates for the management of obesity and associated comorbidities. Among them, miR-1 could be a potential biomarker for metabolic diseases and contribute to metabolic homeostasis. However, thorough research is required to fully elucidate the impact of miR-1 on human adipocyte thermogenesis and metabolism.

View Article and Find Full Text PDF

Background: MicroRNAs (miRNAs) are closely related to cardiovascular diseases, including chronic heart failure (CHF). Endothelial dysfunction can lead to heart failure. The purpose of this study was to evaluate the clinical significance of miR-1285-3p in CHF patients, with the aim of identifying a novel and effective biomarker for CHF.

View Article and Find Full Text PDF

Exploring the role of OIP5-AS1 in the mechanisms of delayed fracture healing: functional insights and clinical implications.

J Orthop Surg Res

January 2025

Department of Orthopaedics, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), No. 818, Renminzhong Road, Wuling District, Changde, 415000, Hunan, China.

Objective: Fracture is a common traumatic disease and there is a risk of delayed healing after fracture occurs. This study aimed to explore the regulatory roles and clinical implications of OIP5-AS1 in delayed fracture healing.

Methods: The study included 80 normal fracture healing patients and 80 delayed fracture healing patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!